Biomea Fusion, Inc. Earnings Per Share (Basic)
Biomea Fusion, Inc. (BMEA) reported Earnings Per Share (Basic) of -$0.12 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-05
- Biomea Fusion, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.12.
- Biomea Fusion, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.17.
- Biomea Fusion, Inc. earnings per share, basic for the quarter ending 2025-12-31 was $0.06.
- Biomea Fusion, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.27.
- Biomea Fusion, Inc. earnings per share, basic for fiscal 2025 was -$1.18.
- Biomea Fusion, Inc. earnings per share, basic for fiscal 2024 was -$3.83.
- Biomea Fusion, Inc. earnings per share, basic for fiscal 2023 was -$3.44.
- Biomea Fusion, Inc. earnings per share, basic for fiscal 2022 was -$2.80.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.12 10-Q · filed 2026-08-05 | -$0.29 10-Q · filed 2026-08-05 | -$0.22 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$0.47 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2026-03-31 | -$0.17 10-Q · filed 2026-05-11 | -$0.11 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$0.36 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$0.74 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-12-31 | $0.06 derived: net income ÷ weighted average shares · filed 2026-03-24 | -$0.18 derived: net income ÷ weighted average shares · filed 2026-03-24 | -$0.57 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$1.18 10-K · filed 2026-03-24 |
| 2025-09-30 | -$0.27 10-Q · filed 2025-11-04 | -$0.74 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$1.45 10-Q · filed 2025-11-04 | -$2.21 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-06-30 | -$0.51 10-Q · filed 2026-08-05 | -$1.29 10-Q · filed 2026-08-05 | -$2.10 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$2.99 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-03-31 | -$0.80 10-Q · filed 2026-05-11 | -$1.61 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$2.51 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$3.54 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2024-12-31 | -$0.81 10-K · filed 2025-03-31 | -$1.71 derived: net income ÷ weighted average shares · filed 2025-11-04 | -$2.75 derived: net income ÷ weighted average shares · filed 2025-11-04 | -$3.83 10-K · filed 2026-03-24 |
| 2024-09-30 | -$0.91 10-Q · filed 2025-11-04 | -$1.94 derived: net income ÷ weighted average shares · filed 2025-11-04 | -$3.03 10-Q · filed 2025-11-04 | -$4.00 derived: net income ÷ weighted average shares · filed 2025-11-04 |
| 2024-06-30 | -$1.03 10-Q · filed 2025-08-05 | -$2.12 10-Q · filed 2025-08-05 | -$3.10 derived: net income ÷ weighted average shares · filed 2025-11-04 | -$3.90 derived: net income ÷ weighted average shares · filed 2025-11-04 |
| 2024-03-31 | -$1.09 10-Q · filed 2025-05-05 | -$2.06 derived: net income ÷ weighted average shares · filed 2025-11-04 | -$2.86 derived: net income ÷ weighted average shares · filed 2025-11-04 | -$3.57 derived: net income ÷ weighted average shares · filed 2025-11-04 |
| 2023-12-31 | -$0.98 10-K · filed 2025-03-31 | -$1.77 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$2.48 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$3.44 10-K · filed 2026-03-24 |
| 2023-09-30 | -$0.80 10-K · filed 2025-03-31 | -$1.50 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$2.46 10-Q · filed 2024-10-29 | -$3.31 derived: net income ÷ weighted average shares · filed 2025-03-31 |
| 2023-06-30 | -$0.70 10-K · filed 2025-03-31 | -$1.66 10-Q · filed 2024-07-31 | -$2.52 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$3.30 derived: net income ÷ weighted average shares · filed 2025-03-31 |
| 2023-03-31 | -$0.98 10-K · filed 2025-03-31 | -$1.84 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$2.62 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$3.22 derived: net income ÷ weighted average shares · filed 2025-03-31 |
| 2022-12-31 | -$0.86 10-K · filed 2024-03-28 | -$1.64 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$2.23 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$2.80 10-K · filed 2025-03-31 |
| 2022-09-30 | -$0.78 10-K · filed 2024-03-28 | -$1.37 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$1.93 10-Q · filed 2023-10-30 | -$2.44 derived: net income ÷ weighted average shares · filed 2024-03-28 |
| 2022-06-30 | -$0.59 10-K · filed 2024-03-28 | -$1.15 10-Q · filed 2023-07-31 | -$1.66 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$2.09 derived: net income ÷ weighted average shares · filed 2024-03-28 |
| 2022-03-31 | -$0.56 10-K · filed 2024-03-28 | -$1.07 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$1.50 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$1.85 derived: net income ÷ weighted average shares · filed 2024-03-28 |
| 2021-12-31 | -$0.51 10-K · filed 2023-03-28 | -$0.94 derived: net income ÷ weighted average shares · filed 2023-03-28 | -$1.29 derived: net income ÷ weighted average shares · filed 2023-03-28 | -$1.74 10-K · filed 2024-03-28 |
| 2021-09-30 | -$0.43 10-K · filed 2023-03-28 | -$0.78 derived: net income ÷ weighted average shares · filed 2023-03-28 | -$1.21 10-Q · filed 2022-11-07 | |
| 2021-06-30 | -$0.33 10-K · filed 2023-03-28 | -$0.77 derived: net income ÷ weighted average shares · filed 2023-03-28 | ||
| 2021-03-31 | -$0.49 10-K · filed 2023-03-28 | |||
| 2020-12-31 | -$0.51 10-K · filed 2023-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |